Navigation Links
Sciele Pharma Announces Successful Completion of New Sular,Formulation Clinical Trial Program

ATLANTA--(BUSINESS WIRE)--May 14, 2007--Sciele Pharma, Inc. (NASDAQ:SCRX) today announced the successful completion of the clinical trial program for its new Sular formulation. The study results showed that the new Sular formulation is bioequivalent to Sciele's currently marketed Sular. The new Sular formulation utilizes SkyePharma's (LSE:SKP) patented Geomatrix technology, which is designed to provide a lower dose of Sular for each of its current doses.

The data from this study will be combined with the results from the previous clinical trial in the Company's new Sular formulation supplemental New Drug Application (sNDA) filing. As previously announced, the Company confirms its expectation to file an sNDA with the U.S. Food and Drug Administration by end of the second quarter of 2007.

About Sciele Pharma, Inc.

Sciele Pharma, Inc. is a pharmaceutical company specializing in sales, marketing and development of branded prescription products focused on Cardiovascular/Diabetes and Women's Health. The Company's Cardiovascular/Diabetes products treat patients with high cholesterol, hypertension, high triglycerides, unstable angina and Type 2 diabetes, and its Women's Health products are designed to improve the health and well-being of women and mothers and their babies. Founded in 1992 and headquartered in Atlanta, Georgia, Sciele Pharma employs more than 800 people. The Company's success is based on placing the needs of patients first, improving health and quality of life, and implementing its business platform - an Entrepreneurial Spirit, Innovation, Speed of Execution, Simplicity, and Teamwork.

About SkyePharma PLC

Using its proprietary drug delivery technologies, SkyePharma develops new formulations of known molecules to provide a clinical advantage and life-cycle extension. The Company has ten approved products in the areas of oral, inhalation and topical delivery. The Company
'"/>




Page: 1 2 3 4

Related medicine technology :

1. SkyePharma and Sciele Pharma Announce Successful Completion of New Sular Formulation Clinical Trial Programme
2. Sygnis Pharma AG announces date for presentation of clinical results
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
(Date:9/17/2014)... , Sept. 17, 2014 BRIC ... Summary GlobalData,s new report, "BRIC ... market data on the BRIC Gynecological Devices market. ... dollars, volume (in units) and average prices (in ... Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization ...
(Date:9/17/2014)... , Sept. 17, 2014 The ... the last decade due to the recession, ... and technological advancements. This BCC Research report ... segments of the ambulance and emergency medical ... blood and hemorrhage control devices, equipment used ...
(Date:9/17/2014)... 17, 2014 Pomerantz LLP is investigating claims ... BioPharma" or the "Company") (NASDAQ: PDLI).  Such investors are ... rswilloughby@pomlaw.com or 888-476-6529, ext. 237. ... its officers and/or directors have violated Sections 10(b) and ... On September 17, 2014, the Company announced ...
Breaking Medicine Technology:BRIC Gynecological Devices Market Outlook to 2020 2BRIC Gynecological Devices Market Outlook to 2020 3Ambulance and Emergency Equipment: Global Markets 2Ambulance and Emergency Equipment: Global Markets 3Ambulance and Emergency Equipment: Global Markets 4SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PDL BioPharma, Inc. - PDLI 2
... Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... subsidiaries, Valeant Pharmaceuticals North America LLC (VPNA) and ... agreement to acquire the assets of the Ortho ... pay Janssen $345 million for the assets, which ...
... Inc. (Nasdaq: CPIX ) announced today that ... market closes on Thursday, August 4, 2011.  A conference call ... 4, 2011, at 5:00 p.m. Eastern Time to discuss the ... 877-303-1298 (for U.S. callers) or 253-237-1032 (for international callers).  A ...
Cached Medicine Technology:Valeant Pharmaceuticals Agrees to Acquire Ortho Dermatologics 2Valeant Pharmaceuticals Agrees to Acquire Ortho Dermatologics 3
(Date:9/18/2014)... Randy Dotinga HealthDay Reporter ... who have the largest number of post-traumatic stress disorder symptoms ... to food, a new study suggests. The findings ... or becoming addicted to food. And it,s also possible that ... PTSD, or both. Still, the research seems to ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 Fit Body ... the fastest-selling fitness business in the country and its popularity, ... has continued to grow enormously in 2014. , The ... Conference, is taking place in Costa Mesa, CA on September ... the biggest conferences yet. Founder Bedros Keuilian, who is also ...
(Date:9/18/2014)... It is true that a ... building a successful brand or business online. Best ... recently compared plenty of professional web hosting suppliers ... and iPage are the best VPS hosting suppliers ... web hosting. All-sized businesses or enterprises can find ...
(Date:9/18/2014)... 18, 2014 In Pretrial Order ... Compel Discovery; Motion for Protective Order ), the ... the subject of multiple telephone conferences.” The first ... “new process for the collection, retention, storage, and ... mesh revision or removal procedures,” which process was ...
(Date:9/18/2014)... September 18, 2014 SMI ... MEMS low pressure sensor Series designed especially ... accuracy. The unique gage and differential offering allows ... 14-Bit resolution and 1% accuracy provide the user ... per year provides the reliability and long-term reliability ...
Breaking Medicine News(10 mins):Health News:PTSD Link to Food Addiction Seen in Report 2Health News:PTSD Link to Food Addiction Seen in Report 3Health News:With Fit Body Boot Camp World Conference Nearing, Founder Explains the Fitness Boot Camp Franchise’s Success 2Health News:With Fit Body Boot Camp World Conference Nearing, Founder Explains the Fitness Boot Camp Franchise’s Success 3Health News:Best Cheap Hosting USA: GreenGeeks, Arvixe And iPage Are The Best Hosting Suppliers In 2014 2Health News:Transvaginal Mesh Lawsuit News: Court Orders C.R. Bard to Turn Over Relevant Documents to Plaintiffs, the Rottenstein Law Group LLP Reports 2Health News:SMI Launches Digital MEMS Low Pressure Sensor 2
... , MONDAY, June 21 (HealthDay News) -- Using ear tubes ... cochlear implants, a new study finds. , U.S. researchers studied ... received ear tubes before cochlear implants. In 46 (59 percent) ... implantation surgery. In all the other cases, the ear tubes ...
... likely to develop allergies, asthma, study suggests , ... born vaginally pick up different bacteria than those who ... immune systems develop, a new study suggests. , ... born through cesarean sections appear to be more at ...
... DC) A recent study of an ancient language ... with potential applications for today,s world. The study, "Dvandvas, ... to Word," to be published in the June 2010 ... authored by Paul Kiparsky of Stanford University. A preprint ...
... the industrial chemical bisphenol A, or BPA, in the womb ... according to a new study conducted in animals. The results ... Meeting in San Diego. "We are seeing changes in ... that are lower than what the Food and Drug Administration ...
... 21, 2010 The recent revelation that the chair ... (IDRC) was a tobacco executive until April 2010 sends ... is no longer a priority, states an editorial ... ). "There is simply no place for the ...
... ... there is promoter activity behind the website. , ... (PRWEB) June 21, 2010 -- The Active Search Results Search Engine ( ... Ranking Technology (ASR Ranking). , , ,ASR Ranking allows search engines to rank search ...
Cached Medicine News:Health News:Ear Tubes Appear to Be Safe Before Cochlear Implantation 2Health News:Delivery Method May Determine the Bacteria Babies Acquire 2Health News:Delivery Method May Determine the Bacteria Babies Acquire 3Health News:The 'bumpy ride' of linguistic change 2Health News:Early-life exposure to BPA may affect testis function in adulthood 2Health News:CMAJ calls for resignation of IDRC chair Barbara McDougall 2Health News:Active Search Results Announces its New Search Engine Ranking Algorithm 2Health News:Active Search Results Announces its New Search Engine Ranking Algorithm 3
Daubenspeck sharp curette, 8....
Bruns bone curette, 9, oval, solid actagonal handle....
MRI curette, 8.5" overall length....
15" overall length, 5" handle....
Medicine Products: